Vis enkel innførsel

T cell responses to SARS-CoV-2 vaccination differ by disease-modifying therapy for multiple sclerosis

dc.contributor.authorWolf, Asia-Sophia Fumika Michaela
dc.contributor.authorRavussin, Anthony
dc.contributor.authorKönig, Marton
dc.contributor.authorØverås, Mathias Herstad
dc.contributor.authorSolum, Guri
dc.contributor.authorKjønstad, Ingrid Fadum
dc.contributor.authorChopra, Adity
dc.contributor.authorHolmøy, Trygve
dc.contributor.authorHarbo, Hanne-Cathrin Flinstad
dc.contributor.authorSyversen, Silje Watterdal
dc.contributor.authorJørgensen, Kristin Kaasen
dc.contributor.authorHøgestøl, Einar August
dc.contributor.authorVaage, John T.
dc.contributor.authorCelius, Elisabeth Gulowsen
dc.contributor.authorLund-Johansen, Fridtjof
dc.contributor.authorMunthe, Ludvig Andre
dc.contributor.authorNygaard, Gro Owren
dc.contributor.authorMjaaland, Siri
dc.date.accessioned2024-10-08T06:14:49Z
dc.date.available2024-10-08T06:14:49Z
dc.date.created2023-09-18T12:31:42Z
dc.date.issued2023
dc.identifier.citationJCI Insight. 2023, 8 (12), .
dc.identifier.issn2379-3708
dc.identifier.urihttps://hdl.handle.net/11250/3156775
dc.language.isoeng
dc.titleT cell responses to SARS-CoV-2 vaccination differ by disease-modifying therapy for multiple sclerosis
dc.title.alternativeT cell responses to SARS-CoV-2 vaccination differ by disease-modifying therapy for multiple sclerosis
dc.typePeer reviewed
dc.typeJournal article
dc.description.versionpublishedVersion
dc.source.pagenumber14
dc.source.volume8
dc.source.journalJCI Insight
dc.source.issue12
dc.identifier.doi10.1172/jci.insight.165111
dc.identifier.cristin2176013
dc.relation.projectNorges forskningsråd: 328657
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1


Tilhørende fil(er)

Thumbnail
Filnavn:
165111.2-20230616043157-covere ...
Størrelse:
1.666Mb
Format:
PDF
Åpne

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel